FDA.reportPublic FDA data

3 CONCEPT EYES LIQUID FOUNDATION IVORY BEIGE

Manufacturer
NANDA CO., LTD. | COSMAX INC.
Effective date
2013-10-03
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:37:08

Label at a glance#

Product3 CONCEPT EYES LIQUID FOUNDATION IVORY BEIGE
Active ingredientTitanium Dioxide
Label structure8 sections

Indications and uses

Indication and usage 1. Always close the lid after use.2. Keep this product in the room temperature.

Dosage and administration

Dosage and administration Put the suitable amount of foundation on a sponge or a foundation brush, and apply it evenly on your face.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active ingredients: Titanium Dioxide 9.294%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive ingredients: Cyclopentasiloxane,Glycerin, Butylene Glycol,Pentaerythrityl Tetraethylhexanoate,Lauryl PEG/PPG-18/18 Methicone,Butylene Glycol Dicaprylate/Dicaprate,Hexyl Laurate, Mineral Oil,Polymethylsilsesquioxane,Talc, Polyglyceryl-4 Isostearate,Iron Oxides (CI 77492), Magnesium Sulfate,Disteardimonium Hectorite,Dimethicone/Vinyl Dimethicone Crosspolymer,Isostearic Acid, Cetyl PEG/PPG-10/1 Dimethicone,Stearic Acid, Trihydroxystearin,Methylparaben,Sorbitan Sesquioleate,Aluminum Stearate,Chlorphenesin,Triethoxycaprylylsilane,Aluminum Hydroxide,Iron Oxides (CI 77491),Fragrance(Parfum), Propylparaben,Iron Oxides (CI 77499),Sodium Hyaluronate,Phenoxyethanol,Pearl Powder,Diamond powder,Ruby Powder,Coral Powder,Butylparaben,Ethylparaben,Isobutylparaben,Amethyst Powder,Tourmaline

PURPOSE

OTC - PURPOSE SECTION

Purpose: Sunscreen

WARNINGS

WARNINGS SECTION

Warnings Keep out of eyes. Stop use if irritation occurs. Keep out of reach of babies and children.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of babies and children.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Indication and usage 1. Always close the lid after use.2. Keep this product in the room temperature.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage and administration Put the suitable amount of foundation on a sponge or a foundation brush, and apply it evenly on your face.

PACKAGE LABEL. PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-138809204037551GTIN-13: 8809204037551
EAN-13: 8809204037551
GTIN storage (14 digits): 08809204037551		3 concept eyes liquid foundation ivory beige carton.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
60764-007-012020-01-31C16284748780-19d75b9d1-074a-f424-e053-dadaa90a57cea7d04b66-ed9d-4c19-a288-0251f6ab26c8

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
60764-007-013 CONCEPT EYES LIQUID FOUNDATION IVORY BEIGE30 mL in 1 CARTONCREAM301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60764-0073 CONCEPT EYES LIQUID FOUNDATION IVORY BEIGE (TITANIUM DIOXIDE) CREAM [NANDA CO., LTD.]1Legacy NDC, 1 package rows20131003_a7d04b66-ed9d-4c19-a288-0251f6ab26c8.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Titanium DioxideACTIVE INGREDIENT15FIX9V2JP1
TITANIUM DIOXIDEACTIVE MOIETY15FIX9V2JP1
Butylene GlycolINACTIVE INGREDIENT3XUS85K0RA1
Pentaerythrityl TetraethylhexanoateINACTIVE INGREDIENTXJ7052W8971

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
60764-00760764-007-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
Titanium Dioxide15FIX9V2JPACTIB
Butylene Glycol3XUS85K0RAIACT
Pentaerythrityl TetraethylhexanoateXJ7052W897IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 2 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Butylene GlycolBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii candidate
2 equally ranked IID candidates
Butylene GlycolBUTYLENE GLYCOL3XUS85K0RASYSTEM / TRANSDERMAL8.12 mgExact identifier — unii candidate
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0feb4cc7-5e70-42f7-ab82-97a8b2dc0b2da7d04b66-ed9d-4c19-a288-0251f6ab26c82013-10-03WarningsExact identifier
spl id: 0feb4cc7-5e70-42f7-ab82-97a8b2dc0b2d
spl set id: a7d04b66-ed9d-4c19-a288-0251f6ab26c8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.